Clinical Trials
All Clinical Trials - Page 75 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00669786Phase 3Completed
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin
- NCT01629420Phase 2Completed
A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
Gonadorelin
- NCT02065323Phase 2Withdrawn
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Gonadorelin
- NCT05183802N/AApproved For Marketing
An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
Setmelanotide
- NCT02223416Phase 1Completed
A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo
Teriparatide
- NCT00046137Phase 3Completed
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00002252N/ACompleted
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
Octreotide
- NCT00227773Phase 2Withdrawn
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
Octreotide
- NCT02217826Phase 1Completed
Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
Octreotide
- NCT00002253N/ACompleted
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.
Octreotide
- NCT00916916N/AUnknown
Lanreotide Levels in Acromegaly
Lanreotide